Shorter-acting glucagon-like peptide-1 receptor agonists are associated with increased development of gastro-oesophageal reflux disease and its complications in patients with type 2 diabetes mellitus: a population-level retrospective matched cohort study
Ozempic puede causar efectos secundarios graves, entre ellos: Inflamacin del pncreas (pancreatitis)
By incorporating glucagon receptor agonism, the compound introduces a third metabolic pathway not present in dual-agonists: Increased energy expenditure: GCG activation is associated with elevated resting metabolic rates in animal models
The change in pace is completely normal and doesnt mean your plan has stopped working
GLP-1 RAs also delay gastric emptying, which contributes to satiety but may exacerbate symptoms in patients with pre-existing gastroparesis (He et al., 2022
Exenatide-treated patients had a mean 2.7 point improvement on the MDS-UPDRS, compared to a mean decline of 2.2 points in controls